该KEYVIBE计划:用于治疗晚期恶性瘤的vibostolimab和pembrolizumab
Ronnie Shapira-Frommer1, Jiaxin Niu2, Ruth Perets3
1Division of Oncology and Clinical Research Institute at Rambam, Rambam Medical Center, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, 5265601, Israel.
Future oncology (London, England)
|September 4, 2024
概括
阻断TIGIT的抗体维博斯托利马布 (Vibostolimab) 与布罗利祖马布 ( pembrolizumab) 在晚期癌症中表现有前途. 在KEYVIBE试验中,将评估其在各种瘤和血液癌症中的安全性和有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- TIGIT (具有Ig和ITIM域的T细胞免疫受体) 是一种抑制T细胞活性的免疫检查点受体.
- 维博斯托利马布是一种人性化的IgG1单克隆抗体,旨在阻止TIGIT通路.
- 克服TIGIT介导的免疫抑制是一种增强抗瘤免疫反应的策略.
研究的目的:
- 评估vibostolimab的安全性和疗效,无论是单独治疗还是与pembrolizumab结合使用.
- 在患有晚期固体瘤和血液性恶性瘤的患者中探索基于vibostolimab的疗法.
- 评估共同配制的免疫疗法,以改善治疗的管理.
主要方法:
- 该KEYVIBE计划包括九个临床试验.
- 试验将调查vibostolimab在单一治疗和组合治疗方案中.
- 研究将包括患有各种高级固体瘤和血液性恶性瘤的患者.
主要成果:
- 预先的数据表明vibostolimab与pembrolizumab结合的抗瘤活性有希望.
- 预计KEYVIBE计划的进一步结果将阐明临床效用.
- 同配方策略旨在解决顺序免疫疗法管理中的挑战.
结论:
- 维博斯托利马布通过向TIGIT途径,代表了癌症治疗的潜在治疗选择.
- 该KEYVIBE计划对于了解vibostolimab在各种癌症中的临床益处至关重要.
- 组合免疫疗法,包括vibostolimab,有可能改善患者的治疗结果.
关键词:
在PD-1中使用PD-1.这是一个紧张的紧张.临床试验是指临床试验中的临床试验.血液学 血液学免疫疗法 免疫疗法这就是Pembrolizumab.固体瘤是一种固体瘤.这就是Vibostolimab.更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.2K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.4K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K